Livarol in the treatment of chronic vulvovaginal candidiasis
نویسندگان
چکیده
منابع مشابه
Chronic vulvovaginal candidiasis.
Frequently ignored by the medical community, chronic vulvovaginal symptoms are relatively common and can frustrating for patients and physicians. Establishing a proper diagnosis will lay the foundation for an effective therapeutic therapeutic plan. Fungal cultures are an important component of the work-up. The most common causes of chronic vaginal symptoms are recurrent vulvovaginal candidiasis...
متن کاملTreatment Considerations in Vulvovaginal Candidiasis
In 1990, more than 13 million American women received prescriptions for treating vaginitis-the most common reason for visiting the gynecologist. (1) Vaginitis caused by yeast species accounts for approximately 40% of these cases, second only to bacterial vaginosis (45%). (2,3) The incidence of vulvovaginal candidiasis (VVC) has increased dramatically in the past decade. In the United Kingdom, t...
متن کاملProbiotics in the treatment of vulvovaginal candidiasis
Probiotics in the treatment of vulvovaginal candidiasis as hydrogen peroxide1, 2,4,5,6. A number of factors are thought to disturb the balance of vaginal micro-flora, including repeated antibiotic use, hormonal imbalances, chronic stress and a processed diet7, 9. Opportunistic pathogens, such as the yeast Candida, may take advantage of this change in the vaginal environment. Although Candida is...
متن کاملCoping with chronic vulvovaginal candidiasis
33 Key points • Vulvovaginal candidiasis (VVC) covers a disease spectrum, from a single episode to chronic disease with unremitting symptoms. • The concept of chronic VVC was recently described; it is a common cause of chronic nonerosive vulvo vaginitis in women present ing at vulval disease clinics. • Evidence suggests chronic VVC is a hyper sensitivity response to commensal Candida spp. • In ...
متن کاملTreatment of chronic vulvovaginal candidiasis with posaconazole and ciclopiroxolamine
Therapy of chronic recurrent vulvovaginal candidiasis (VVC) caused by Candida glabrata is still rare in comparison to C. albicans infection, but therapy remains more difficult. Combination therapy with topical antifungals may improve therapy outcome, but still standard agents as fluconazole or itraconazole often fail. Posaconazole is a new systemic triazole with a wide antifungal spectrum inclu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Reproductive Endocrinology
سال: 2017
ISSN: 2411-1295,2309-4117
DOI: 10.18370/2309-4117.2017.35.81-83